RXRX Return on Equity (ROE) Analysis
Updated 155h ago·SEC filings & market data
Key Takeaway
A Return on Equity (ROE) of -56.6% means RXRX is losing $0.566 for every dollar of shareholder equity, indicating the company is burning through invested capital rather than generating profit.
Sector Performance
4th percentileRXRX
-56.6%
Sector Median
13.3%
Sector Avg
17.0%
Prior Period
-57.2%(Aug 2026)
Deep Analysis
A Return on Equity (ROE) of -56.6% means RXRX is losing $0.566 for every dollar of shareholder equity, indicating the company is burning through invested capital rather than generating profit.
This sits far below the sector median of 13.5%, placing the company in the 5th percentile among peers—meaning 95% of comparable firms have a higher ROE. The trend is largely undefined: year-over-year change is N/A, but the most recent quarter shows +1.0% improvement, with historical values moving from -57.2% to -56.6%. A deeply negative ROE combined with a marginal quarterly improvement signals persistent losses with only a faint sign of stabilization, posing high investment risk rather than opportunity. This metric directly contradicts any expectation of profitability and supports the overall CAUTIOUS verdict on the stock.
Frequently Asked Questions
What does the Return on Equity (ROE) tell investors about RXRX?
ROE measures how effectively management turns equity into profit. Consistently above 15% is typically considered strong. Negative equity distorts this metric.
How is the Return on Equity (ROE) calculated?
Return on Equity (ROE) is calculated as: Net Income / Shareholders' Equity.
Who are RXRX's closest peers by Return on Equity (ROE)?
The closest peers by Return on Equity (ROE) include: EVGO (-34.6%), MAR (-69.0%), BMBL (-76.9%), WBA (-82.7%), NIO (-84.0%).
Learn More About Return on Equity (ROE)
The Formula
Net Income / Shareholders' Equity
Why It Matters
ROE measures how effectively management turns equity into profit. Consistently above 15% is typically considered strong. Negative equity distorts this metric.
Master RXRX's Valuation
Get the complete institutional research report covering all fundamental and technical metrics.
View full RXRX research report →RXRX
-56.6%
Sector Median
13.3%
Sector Avg
17.0%
How RXRX's Return on Equity (ROE) compares to sector peers.
Also Analyze
Not financial advice. Research tool only. Data may be delayed.